Advanced Search
Displaying assets from 1 to 30 out of 7
-
Description LAIV efficacy in placebo‐controlled pediatric studies
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses -
Description Phenotypic characteristics and phenotype‐controlling genes for MDVs and vaccine reassortants2–5
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses -
Description Summary of solicited events observed within 7 days after one dose of LAIV or placebo to adults 18–64 years of age (study AV009)
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses -
Description Effectiveness of LAIV in reducing illness in adults 18–64 years of age (study AV009). *P < 0·05; †P < 0·001. CDC‐ILI, influenza‐like illness as defined by the Centers for Disease Control and...
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses -
Description Incidence of reactogenicity events within 10 days after administration of doses 1 and 2 of LAIV or placebo to children 2–6 years of age (studies AV006, D153‐P501)
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses -
Description Schematic diagram of LAIV vaccine seed strain preparation using reverse genetics. Plasmids containing the MDV genes that control ca, ts, and att phenotypes and wild‐type virus HA and NA genes are...
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses -
Description LAIV efficacy relative to TIV in active‐controlled pediatric studies
Article Title: Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Publication Title: Influenza and Other Respiratory Viruses